- HealthTech
- Monday, 18 May 2020
Philips Healthcare US to Include SyntheticMR's Solution in Product Catalogue
"Healthcare providers in North America through this collaboration will now have quicker access to a solution that can help shorten scan times, improve patient throughput and provide quantitative data, which will be critical in post COVID-19 times," says Kyle Frye, President SyntheticMR Inc. "I am excited to accelerate our growth on the US market together with Philips Healthcare and for their sales team to begin selling our product by mid-June."
Philips Healthcare currently offers the quantitative sequence SyntAc as an option to their customers, and adding SyntheticMR's software solution enables the customer to generate multiple contrast-weighted images and volumetric data in a single 5-6 minute scan. SyntheticMR's product is compatible with most MRI scanners from Philips Healthcare.
"Philips Healthcare is an important partner in our ambitions to provide customers with workflow improvements and objective decision support," says Ulrik Harrysson, CEO, SyntheticMR AB. "This agreement is an important step for a closer collaboration with Philips Healthcare on a global level."
Related Industry Updates
North America Intraoperative Neuromonitoring Market Impressive Gains including key Players Like Accurate Monitoring, IntraNerve Neuroscience Holdings, LLC, NuVasive
Dec 28, 2020
Autoimmune Treatment Market Set To Grow According To Forecasts Due To Increasing Prevalence Of Obesity
Jan 04, 2021
Explore why South Africa Anti-Infective Market is Thriving Worldwide 2020-2027 with an increase in Revenue of $2572.5Mn
Oct 09, 2020
Small Animal Imaging Market Analysis By Strategic Growth Rate And Factors (2020-2027)
Dec 03, 2020
US Occupational Health Market is expected to reach US$ 1,496.92 million by 2028
Mar 22, 2023
Cosmetovigilance Market lucrative opportunities by 2027 examined in new market research report
May 10, 2021
Companion Animal Parasiticides Market SWOT Analysis of Key Players- Elanco, Zoetis, Merck, Virbac, Bayer AG
Apr 14, 2021